Aude Dupré, Louise Boyer-Chatenet, Rose M Sattler, Ami P Modi, Ji-Hoon Lee, Matthew L Nicolette, Levy Kopelovich, Maria Jasin, Richard Baer, Tanya T Paull, Jean Gautier
Columbia University, Institute for Cancer Genetics, Irving Cancer Research Center, 1130 St. Nicholas Avenue, Room 602, New York, New York 10032, USA.
Nature chemical biology 2008 FebThe MRN (Mre11-Rad50-Nbs1)-ATM (ataxia-telangiectasia mutated) pathway is essential for sensing and signaling from DNA double-strand breaks. The MRN complex acts as a DNA damage sensor, maintains genome stability during DNA replication, promotes homology-dependent DNA repair and activates ATM. MRN is essential for cell viability, which has limited functional studies of the complex. Small-molecule inhibitors of MRN could circumvent this experimental limitation and could also be used as cellular radio- and chemosensitization compounds. Using cell-free systems that recapitulate faithfully the MRN-ATM signaling pathway, we designed a forward chemical genetic screen to identify inhibitors of the pathway, and we isolated 6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (mirin, 1) as an inhibitor of MRN. Mirin prevents MRN-dependent activation of ATM without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Consistent with its ability to target the MRN complex, mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells.
Aude Dupré, Louise Boyer-Chatenet, Rose M Sattler, Ami P Modi, Ji-Hoon Lee, Matthew L Nicolette, Levy Kopelovich, Maria Jasin, Richard Baer, Tanya T Paull, Jean Gautier. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nature chemical biology. 2008 Feb;4(2):119-25
PMID: 18176557
View Full Text